Mission Statement

The Institutional Review Board (IRB) Administration is committed to following the federal regulations to protect the rights and welfare of human subjects involved in research conducted under the auspices of the PMT Research Institute.

Responsibility

Under the U.S. Food and Drug Administration (FDA) regulations, an institutional review board (IRB) is an appropriately constituted group that has been formally designated to review and monitor biomedical research involving human subjects. In accordance with FDA regulations, an IRB has the authority to approve, require modifications in (to secure approval), or disapprove research. This group review serves an important role in the protection of the rights and welfare of human research subjects.

The purpose of IRB review is to assure, both in advance and by periodic review, that appropriate steps are taken to protect the rights and welfare of humans participating as subjects in the research. To accomplish this purpose, IRBs use a group process to review research protocols and related materials (e.g., informed consent documents and investigator brochures) to ensure protection of the rights and welfare of human subjects of research.